NFATc 3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis of Idiopathic Pulmonary Fibrosis

  2016cited by this paper
• Effect of Hypoxia on Fibroblast Proliferation in Idiopathic Pulmonary Fibrosis

  2016cited by this paper
• Role of VPAC2 receptor in monocrotaline-induced pulmonary hypertension in rats.

  2014cited by this paper
• Genome-wide Approaches Reveal Functional Vascular Endothelial Growth Factor (VEGF)-inducible Nuclear Factor of Activated T Cells (NFAT) c1 Binding to Angiogenesis-related Genes in the Endothelium*

  2014cited by this paper
• Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity.

  2014cited by this paper
• Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis

  2014cited by this paper
• The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases.

  2013cited by this paper
• Silencing of STIM1 attenuates hypoxia-induced PASMCs proliferation via inhibition of the SOC/Ca2+/NFAT pathway

  2013cited by this paper
• Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.

  2013cited by this paper
• Angiogenesis in pulmonary fibrosis: too much or not enough?

  2012cited by this paper
• The pathogenesis of COPD and IPF: Distinct horns of the same devil?

  2012cited by this paper
• Signal Transducers and Activators of Transcription-3/Pim1 Axis Plays a Critical Role in the Pathogenesis of Human Pulmonary Arterial Hypertension

  2011cited by this paper
• NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis.

  2011cited by this paper
• NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal mice.

  2011cited by this paper
• VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension

  2011cited by this paper
• Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries.

  2011cited by this paper
• Adenoviral transfer of vasoactive intestinal peptide (VIP) gene inhibits rat aortic and pulmonary artery smooth muscle cell proliferation.

  2009cited by this paper
• [Pathogenesis of chronic obstructive pulmonary disease].

  2009cited by this paper
• Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.

  2009cited by this paper
• Pulmonary Hypertension in COPD: A Review and Consideration of the Role of Arterial Vasodilators

  2009cited by this paper
• The Vasoactive Intestinal Peptide Gene Is a Key Modulator of Pulmonary Vascular Remodeling and Inflammation

  2008cited by this paper
• NFATc3 is required for intermittent hypoxia-induced hypertension.

  2008cited by this paper
• Activation of NFATc3 down-regulates the beta1 subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension.

  2007cited by this paper
• NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation.

  2007cited by this paper
• The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

  2007cited by this paper
• Nuclear Factor of Activated T Cells and Serum Response Factor Cooperatively Regulate the Activity of an α-Actin Intronic Enhancer*

  2005cited by this paper
• Disrupted circadian rhythms in VIP- and PHI-deficient mice.

  2003cited by this paper
• Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

  2003cited by this paper
• Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

  2003cited by this paper
• Enhancement of Systemic and Pulmonary Vasoconstriction by β‐Amyloid Peptides and its Suppression by Vasoactive Intestinal Peptide

  1998cited by this paper
• Transcription factors of the NFAT family: regulation and function.

  1997cited by this paper
• Dynamic aspects of regulatory lung peptides in chronic hypoxic pulmonary hypertension.

  1992cited by this paper
• Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat.

  1985cited by this paper
• Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma.

  1984cited by this paper
• Relaxant action of VIP on cat pulmonary artery: comparison with acetylcholine, isoproterenol, and PGE1.

  1983cited by this paper

• Neuroimmune Interaction: A Widespread Mutual Regulation and the Weapons for Barrier Organs

  2022cites this paper